当前位置: 首页 >> 检索结果
共有 1935 条符合本次的查询结果, 用时 1.8195196 秒

1461. OLGIM staging and proton pump inhibitor use predict the risk of gastric cancer.

作者: Junya Arai.;Ryota Niikura.;Yoku Hayakawa.;Tomonori Aoki.;Atsuo Yamada.;Takashi Kawai.;Mitsuhiro Fujishiro.
来源: Gut. 2022年71卷5期1043-1044页

1462. Antibiotic use differentially affects the risk of anti-drug antibody formation during anti-TNFα therapy in inflammatory bowel disease patients: a report from the epi-IIRN.

作者: Yuri Gorelik.;Shay Freilich.;Shiran Gerassy-Vainberg.;Sigal Pressman.;Chagit Friss.;Alexandera Blatt.;Gili Focht.;Yiska Loewenberg Weisband.;Shira Greenfeld.;Revital Kariv.;Nathan Lederman.;Iris Dotan.;Naama Geva-Zatorsky.;Shai Shlomo Shen-Orr.;Yechezkel Kashi.;Yehuda Chowers.; .
来源: Gut. 2022年71卷2期287-295页
Anti-drug antibodies (ADA) to anti-tumour necrosis factor (anti-TNF) therapy drive treatment loss of response. An association between intestinal microbial composition and response to anti-TNF therapy was noted. We therefore aimed to assess the implications of antibiotic treatments on ADA formation in patients with inflammatory bowel disease (IBD).

1463. Antibody response to SARS-CoV-2 among individuals with IBD diminishes over time: a serosurveillance cohort study.

作者: Gilaad G Kaplan.;Christopher Ma.;Carmen Charlton.;Jamil N Kanji.;Graham Tipples.;Nastaran Sharifi.;Michelle Herauf.;Stephanie Coward.;Richard J M Ingram.;Lindsay Hracs.;Eric I Benchimol.;Remo Panaccione.
来源: Gut. 2022年71卷6期1229-1231页

1464. The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinoma.

作者: Bernd Heinrich.;E Michael Gertz.;Alejandro A Schäffer.;Amanda Craig.;Benjamin Ruf.;Varun Subramanyam.;John C McVey.;Laurence P Diggs.;Sophia Heinrich.;Umberto Rosato.;Chi Ma.;Chunhua Yan.;Ying Hu.;Yongmei Zhao.;Tsai-Wei Shen.;Veena Kapoor.;William Telford.;David E Kleiner.;Merril K Stovroff.;Harmeet S Dhani.;Jiman Kang.;Thomas Fishbein.;Xin Wei Wang.;E Ruppin.;Alexander Kroemer.;Tim F Greten.;Firouzeh Korangy.
来源: Gut. 2022年71卷6期1161-1175页
Hepatocellular carcinoma (HCC) represents a typical inflammation-associated cancer. Tissue resident innate lymphoid cells (ILCs) have been suggested to control tumour surveillance. Here, we studied how the local cytokine milieu controls ILCs in HCC.

1465. Real-world data for endoscopic therapy in LGD: not looking so good.

作者: Sachin Srinivasan.;Prateek Sharma.
来源: Gut. 2022年71卷8期1457-1458页

1466. Discovery and 3D imaging of a novel ΔNp63-expressing basal cell type in human pancreatic ducts with implications in disease.

作者: Sandrina Martens.;Katarina Coolens.;Mathias Van Bulck.;Tatjana Arsenijevic.;Joan Casamitjana.;Angel Fernandez Ruiz.;Abdessamad El Kaoutari.;Jaime Martinez de Villareal.;Hediel Madhloum.;Farzad Esni.;Yves Heremans.;Gunter Leuckx.;Harry Heimberg.;Luc Bouwens.;Patrick Jacquemin.;Diedert Luc De Paep.;Peter In't Veld.;Nicky D'Haene.;Christelle Bouchart.;Nelson Dusetti.;Jean-Luc Van Laethem.;Wim Waelput.;Pierre Lefesvre.;Francisco X Real.;Meritxell Rovira.;Ilse Rooman.
来源: Gut. 2021年71卷10期2030-42页
The aggressive basal-like molecular subtype of pancreatic ductal adenocarcinoma (PDAC) harbours a ΔNp63 (p40) gene expression signature reminiscent of a basal cell type. Distinct from other epithelia with basal tumours, ΔNp63+ basal cells reportedly do not exist in the normal pancreas.

1467. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer.

作者: Johann von Felden.;Teresa Garcia-Lezana.;Navneet Dogra.;Edgar Gonzalez-Kozlova.;Mehmet Eren Ahsen.;Amanda Craig.;Stacey Gifford.;Benjamin Wunsch.;Joshua T Smith.;Sungcheol Kim.;Jennifer E L Diaz.;Xintong Chen.;Ismail Labgaa.;Philipp Haber.;Reena Olsen.;Dan Han.;Paula Restrepo.;Delia D'Avola.;Gabriela Hernandez-Meza.;Kimaada Allette.;Robert Sebra.;Behnam Saberi.;Parissa Tabrizian.;Amon Asgharpour.;Douglas Dieterich.;Josep M Llovet.;Carlos Cordon-Cardo.;Ash Tewari.;Myron Schwartz.;Gustavo Stolovitzky.;Bojan Losic.;Augusto Villanueva.
来源: Gut. 2021年
Surveillance tools for early cancer detection are suboptimal, including hepatocellular carcinoma (HCC), and biomarkers are urgently needed. Extracellular vesicles (EVs) have gained increasing scientific interest due to their involvement in tumour initiation and metastasis; however, most extracellular RNA (exRNA) blood-based biomarker studies are limited to annotated genomic regions.

1468. Two waves of coeliac disease incidence in Sweden: a nationwide population-based cohort study from 1990 to 2015.

作者: David Bergman.;James King.;Benjamin Lebwohl.;Mark S Clements.;Bjorn Roelstraete.;Gilaad G Kaplan.;Peter Hr Green.;Joseph A Murray.;Jonas F Ludvigsson.
来源: Gut. 2022年71卷6期1088-1094页
To assess the incidence of biopsy-verified coeliac disease (CD) in Sweden and examine the incidence of duodenal/jejunal biopsies with normal mucosa over time as a proxy for CD awareness and investigation.

1469. Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals.

作者: Sonia Tarallo.;Giulio Ferrero.;Francesca De Filippis.;Antonio Francavilla.;Edoardo Pasolli.;Valentina Panero.;Francesca Cordero.;Nicola Segata.;Sara Grioni.;Ruggero Gaetano Pensa.;Barbara Pardini.;Danilo Ercolini.;Alessio Naccarati.
来源: Gut. 2022年71卷7期1302-1314页
MicroRNA (miRNA) profiles have been evaluated in several biospecimens in relation to common diseases for which diet may have a considerable impact. We aimed at characterising how specific diets are associated with the miRNome in stool of vegans, vegetarians and omnivores and how this is reflected in the gut microbial composition, as this is still poorly explored.

1470. Underdevelopment of the gut microbiota and bacteria species as non-invasive markers of prediction in children with autism spectrum disorder.

作者: Yating Wan.;Tao Zuo.;Zhilu Xu.;Fen Zhang.;Hui Zhan.;Dorothy Chan.;Ting-Fan Leung.;Yun Kit Yeoh.;Francis K L Chan.;Ruth Chan.;Siew C Ng.
来源: Gut. 2022年71卷5期910-918页
The gut microbiota has been suggested to play a role in autism spectrum disorder (ASD). We postulate that children with ASD harbour an altered developmental profile of the gut microbiota distinct from that of typically developing (TD) children. Here, we aimed to characterise compositional and functional alterations in gut microbiome in association with age in children with ASD and to identify novel faecal bacterial markers for predicting ASD.

1471. Next-generation sequencing of bile cell-free DNA for the early detection of patients with malignant biliary strictures.

作者: Maria Arechederra.;María Rullán.;Irene Amat.;Daniel Oyon.;Lucia Zabalza.;Maria Elizalde.;M Ujue Latasa.;Maria R Mercado.;David Ruiz-Clavijo.;Cristina Saldaña.;Ignacio Fernández-Urién.;Juan Carrascosa.;Vanesa Jusué.;David Guerrero-Setas.;Cruz Zazpe.;Iranzu González-Borja.;Bruno Sangro.;Jose M Herranz.;Ana Purroy.;Isabel Gil.;Leonard J Nelson.;Juan J Vila.;Marcin Krawczyk.;Krzysztof Zieniewicz.;Waldemar Patkowski.;Piotr Milkiewicz.;Francisco Javier Cubero.;Gorka Alkorta-Aranburu.;Maite G Fernandez-Barrena.;Jesus M Urman.;Carmen Berasain.;Matias A Avila.
来源: Gut. 2022年71卷6期1141-1151页
Despite significant progresses in imaging and pathological evaluation, early differentiation between benign and malignant biliary strictures remains challenging. Endoscopic retrograde cholangiopancreatography (ERCP) is used to investigate biliary strictures, enabling the collection of bile. We tested the diagnostic potential of next-generation sequencing (NGS) mutational analysis of bile cell-free DNA (cfDNA).

1472. Duality of the association between COVID-19 and acute pancreatitis.

作者: Xiu-He Lv.;Kai Deng.;Jin-Lin Yang.
来源: Gut. 2022年71卷1期229页

1473. COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study.

作者: Luca Saverio Belli.;Christophe Duvoux.;Paolo Angelo Cortesi.;Rita Facchetti.;Speranta Iacob.;Giovanni Perricone.;Sylvie Radenne.;Sara Conti.;Damiano Patrono.;Gabriela Berlakovich.;Angus Hann.;Luisa Pasulo.;Lluis Castells.;Francois Faitot.;Olivier Detry.;Federica Invernizzi.;Giulia Magini.;Paolo De Simone.;Ilias Kounis.;Maria Cristina Morelli.;Fernando Díaz Fontenla.;Bo-Göran Ericzon.;Carmelo Loinaz.;Chris Johnston.;Liliana Gheorghe.;Mickael Lesurtel.;Renato Romagnoli.;Dagmar Kollmann.;M Thamara Pr Perera.;Stefano Fagiuoli.;Darius Mirza.;Audrey Coilly.;Christian Toso.;Krzysztof Zieniewicz.;Laure Elkrief.;Vincent Karam.;Rene Adam.;Caroline den Hoed.;Marco Merli.;Massimo Puoti.;Luciano De Carlis.;Gabriel C Oniscu.;Salvatore Piano.;Paolo Angeli.;Constantino Fondevila.;Wojciech G Polak.; .
来源: Gut. 2021年70卷10期1914-1924页
Explore the impact of COVID-19 on patients on the waiting list for liver transplantation (LT) and on their post-LT course.

1474. Optimal timing of cholecystectomy after necrotising biliary pancreatitis.

作者: Nora D Hallensleben.;Hester C Timmerhuis.;Robbert A Hollemans.;Sabrina Pocornie.;Janneke van Grinsven.;Sandra van Brunschot.;Olaf J Bakker.;Rogier van der Sluijs.;Matthijs P Schwartz.;Peter van Duijvendijk.;Tessa Römkens.;Martijn W J Stommel.;Robert C Verdonk.;Marc G Besselink.;Stefan A W Bouwense.;Thomas L Bollen.;Hjalmar C van Santvoort.;Marco J Bruno.; .
来源: Gut. 2022年71卷5期974-982页
Following an episode of acute biliary pancreatitis, cholecystectomy is advised to prevent recurrent biliary events. There is limited evidence regarding the optimal timing and safety of cholecystectomy in patients with necrotising biliary pancreatitis.

1475. Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.

作者: Ahmad Salhab.;Johnny Amer.;Yinying Lu.;Rifaat Safadi.
来源: Gut. 2022年71卷7期1373-1385页
Sodium+/ taurocholate cotransporting polypeptide (NTCP) is a membrane transporter affecting the enterohepatic circulation of bile acids (BAs). We aimed to evaluate NTCP's roles in humans and animal models of liver fibrosis (LF).

1476. Automated sizing of colorectal polyps using computer vision.

作者: Mohamed Abdelrahim.;Hiroyasu Saiga.;Naoto Maeda.;Ejaz Hossain.;Hitoshi Ikeda.;Pradeep Bhandari.
来源: Gut. 2022年71卷1期7-9页

1477. Recent advances in clinical practice: epidemiology of autoimmune liver diseases.

作者: Palak J Trivedi.;Gideon M Hirschfield.
来源: Gut. 2021年70卷10期1989-2003页
Autoimmune liver diseases are chronic inflammatory hepatobiliary disorders that when classically defined encompass three distinctive clinical presentations; primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC) and autoimmune hepatitis (AIH). Meaningful changes in disease epidemiology are reported, with increasing incidence and prevalence of AIH and PSC in Europe, and rising prevalence of PBC across Europe, North America and the Asia-Pacific region. However, there appears to be very significant global variation with contemporary incidence rates of disease per 100 000 ranging from 0.84 to 2.75 for PBC, 0.1 to 4.39 for PSC and 0.4 to 2.39 for AIH. Prevalence corresponds, and per 100 000 estimates for PBC range from 1.91 to 40.2, for PSC between 0.78 and 31.7 and for AIH from 4.8 to 42.9. Population-based studies and multicentre observational cohort series provide improved understanding of the clinical course that patients experience, highlighting variations in presenting phenotypes geographically and temporally. Collectively, while autoimmune liver diseases are rare, the clinical burden is disproportionately high relative to population incidence and prevalence. Age, sex and race also impact clinical outcomes, and patient morbidity and mortality are reflected by high need for gastroenterology, hepatology and organ transplant services.

1478. Proton pump inhibitors and gastric cancer: a population-based cohort study.

作者: Jigar Patel.;Ivan Berezowski.;Rajesh Naidu Janapala.;Ali Pourmand.
来源: Gut. 2022年71卷5期1039-1041页

1479. Incorrectly analysing stratified and minimised trials may lead to wrongfully rejecting superiority of interventions.

作者: Reinier Cornelis Anthonius van Linschoten.;Rachel West.;Desirée van Noord.;Nikki van Leeuwen.
来源: Gut. 2022年71卷5期1038-1039页

1480. Reverse translation approach generates a signature of penetrating fibrosis in Crohn's disease that is associated with anti-TNF response.

作者: Shanshan Xiong.;Charles E Whitehurst.;Li Li.;Gyu Seong Heo.;Chin-Wen Lai.;Umang Jain.;Brian D Muegge.;Scott T Espenschied.;Ryan J Musich.;Minhu Chen.;Yongjian Liu.;Ta-Chiang Liu.;Thaddeus S Stappenbeck.
来源: Gut. 2022年71卷7期1289-1301页
Fibrosis is a common feature of Crohn's disease (CD) which can involve the mesenteric fat. However, the molecular signature of this process remains unclear. Our goal was to define the transcriptional signature of mesenteric fibrosis in CD subjects and to model mesenteric fibrosis in mice to improve our understanding of CD pathogenesis.
共有 1935 条符合本次的查询结果, 用时 1.8195196 秒